Publications

B. Gomez-Mancilla, K. M. Dürsteler, M. Vogel, M. Herdener, M. Torrens, B. P. Gálvez, A. Gual, R. M. Corral, E. I. Kuper, D. L. Mosca, S. Dumitras, N. Pezous, M. Berkheimer, E. Walker, F. Gasparini, J.-H. Cha, R. Dolmetsch, Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial. Sci. Transl. Med. 17, eadi4505 (2025). https://doi.org/10.1126/scitranslmed.adi4505

N. M. Rieser, R. Bitar, S. Halm, C. Rossgoderer, L. P. Gubser, M. Thévenaz, Y. Kreis, R. von Rotz, C. Nordt, M. Visentini, F. Moujaes, E. J. E. Engeli, A. Ort, E. Seifritz, F. X. Vollenweider, M. Herdener, K. H. Preller, Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial. eClinicalMedicine 82, 103149 (2025). https://doi.org/10.1016/j.eclinm.2025.103149

Buschner, M., Heckel, N., Dürler, P., Engeli, E. J. E., Schneider, S., Havelka, E. M., Nordt, C., & Herdener, M. (2024). The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol. International Journal of Drug Policy, 133, 104610.https://doi.org/10.5167/uzh-263527

Engeli EJE, Zoelch N, Hock A, Nordt C, Hulka LM, Kirschner M, Scheidegger M, Esposito F, Baumgartner MR, Henning A, Seifritz E, Quednow BB, Herdener M. Impaired glutamate homeostasis in the nucleus accumbens in human cocaine addiction. Mol Psychiatry, 2020. https://doi.org/10.1038/s41380-020-0828-z

Nordt C, Vogel M, Dey M, Moldovanyi A, Beck T, Berthel T, Walter M, Seifritz E, Dürsteler KM, Herdener M. One size does not fit all: evolution of opioid agonist treatments in a naturalistic setting over 23 years. Addiction 114: 103–111, 2019. https://doi.org/10.1111/add.14442

Vogel M, Nordt C, Bitar R, Boesch L, Walter M, Seifritz E, Dürsteler KM, Herdener M. Cannabis use in Switzerland 2015–2045: A population survey based model. International Journal of Drug Policy 69: 55–59, 2019. https://doi.org/10.1016/j.drugpo.2019.03.008

Kirschner M, Sladky R, Haugg A, Stämpfli P, Jehli E, Hodel M, Engeli E, Hoesli S, Baumgartner MR, Sulzer J, Huys QJM, Seifritz E, Quednow BB, Scharnowski F, Herdener M. Self-regulation of the dopaminergic reward circuit in cocaine users with mental imagery and neurofeedback. EBioMedicine 37: 489–498, 2018. https://doi.org/10.1016/j.ebiom.2018.10.052

Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, Liechti ME, Seifritz E, Vollenweider FX. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol 27: 451–457, 2017. https://doi.org/10.1016/j.cub.2016.12.030

Herdener M, Dürsteler KM, Seifritz E, Nordt C. Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis. Lancet Psychiatry 4: 302–309, 2017. https://doi.org/10.1016/S2215-0366(17)30080-9

Nordt C, Stohler R. Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis. Lancet 367: 1830–1834, 2006. https://doi.org/10.1016/S0140-6736(06)68804-1